ArticleJournal of experimental & clinical cancer research : CR2025

Baseline levels and dynamic changes of cfDNA, tumor fraction and mutations to anticipate the clinical course of small cell lung cancer (SCLC) patients treated with first-line atezolizumab and chemotherapy: an hypothesis generating study (CATS/ML43257).

Giulia Pasello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.